DTL
INFI

Dynamic Technology Lab’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

Dynamic Technology Lab’s Portfolio INFI Stock Details INFI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-12,844
Closed -$38K – 1569
2021
Q2 		$38K Buy
+12,844
New +$40.6K ﹤0.01% 1073
2016
Q2 		– Sell
-13,111
Closed -$69K – 1225
2016
Q1 		$69K Buy
+13,111
New +$80.2K 0.02% 863
2014
Q4 		– Sell
-16,350
Closed -$219K – 930
2014
Q3 		$219K Buy
+16,350
New +$195K 0.11% 465

Other funds holding INFI

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Dynamic Technology Lab's INFI Position: Q3 2021 in Review

Dynamic Technology Lab sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q3 2021, closing a stake of 12,844 shares — an estimated $38K sold.

Dynamic Technology Lab first reported a position in INFI in Q3 2014 and held it in 3 quarters. The position peaked at $219K in Q3 2014. 107 funds tracked by Wall St. Rank hold INFI as of Q3 2021.

  • Dynamic Technology Lab reported no remaining Infinity Pharmaceuticals, Inc. position as of Q3 2021 after selling out during the quarter.
  • Dynamic Technology Lab sold 12,844 Infinity Pharmaceuticals, Inc. shares in Q3 2021, an estimated $38K.
  • Dynamic Technology Lab first reported a position in Infinity Pharmaceuticals, Inc. in Q3 2014 and held it in 3 quarters.
  • Dynamic Technology Lab's Infinity Pharmaceuticals, Inc. position peaked at $219K in Q3 2014.
  • 107 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q3 2021.

Based on Dynamic Technology Lab's 13F filing for Q3 2021, filed 15 Nov 2021.